HUMAN LUNG DISEASES ARE AMONG the most frequent causes of morbidity and mortality in the world (45) . Chronic obstructive pulmonary disease, lung fibrosis, and emphysema, either without a known cause or secondary to other diseases such as infections or autoimmune disorders, are examples of devastating and life-threatening conditions for which effective treatments are still lacking. Even when in some cases the cause is obvious (e.g., smoking, etc.), many aspects of the pathophysiology of lung diseases remain poorly understood. To understand etiology, prevent a disease from fully developing or progressing, and find targets for effective treatment, additional research is essential. Research to unravel disease processes in the lung and to develop new therapeutic strategies in a preclinical setting heavily relies on small animal models (4, 6, 24, 25, 30, 38) . The resulting lung pathology is routinely quantified by labor-intensive ex vivo histological assessments, currently the gold standard for evaluation of pathology and its therapy in these animals. Although histological techniques will always remain essential to unravel pathogenesis at a molecular and cellular level, they lack the ability to provide dynamic information on disease progression and potential therapeutic effects. Because the time of onset, course of disease progression, and potential response to therapy in (transgenic) rodent models may be unpredictable and/or show substantial interindividual variation (23, 25) , noninvasive techniques are indispensable to dynamically monitor disease development and progression and to establish the kinetics of pathogenic events or treatment effects for each animal individually. Because noninvasive pulmonary function measurements have limitations regarding sensitivity, specificity, and available readout (16, 19, 41) , several imaging tools for the evaluation of lung disease are currently being explored (15) . Nonetheless, imaging techniques combining sensitivity with good temporal and spatial resolution in vivo are limited. Based on its excellent air-tissue contrast, in vivo microcomputed tomography (micro-CT) has proven to be an efficient and safe noninvasive method to provide dynamic quantitative information on lung emphysema and fibrosis progression, including therapy response over a time span of several weeks in mice, thereby having experimental, ethical, statistical, and economic advantages compared with the standard histological approach (9) . However, before extending lung micro-CT scanning protocols to animal models that require more frequent scanning and/or scanning over longer periods of time (e.g., in transgenic mouse models with slow and/or unpredictable disease onset), radiotoxicity issues that could interfere with the micro-CT readout for the lung are often raised as a possible concern and must be considered. Because lungs are particularly sensitive to higher (cumulative) doses of radiation and radiation-induced lung inflammation, fibrosis, and carcinogenesis are important manifestations of radiotoxic damage (18, 28, 32) , these are particularly relevant potential confounding factors when using micro-CT in pulmonary research. Moreover, when imaging the lungs in experimental models, longer scanning times are necessary to include respiratory gating to avoid motion artifacts due to breathing and to provide quantitative data regarding tidal volumes (8, 9, 13) . Therefore, X-ray doses and hence the risks for radiation-induced lung injury tend to be higher in micro-CT studies of the lung, compared with other organs. Studies assessing these radiotoxicity issues when using micro-CT for longitudinal mouse lung imaging are primordial but currently lacking. Therefore, we aimed at investigating the potential radiotoxicity of repeated high-resolution retrospectively gated lung micro-CT scans for four different (very) long-term imaging protocols and validated our results with gold standard histochemical techniques to evaluate possible radiotoxicityinduced lung damage, thereby evaluating the safety of micro-CT for routine use in lung research.
MATERIALS AND METHODS

Animals and Study Design
All animal experiments were carried out in compliance with national and European regulations and were approved by the animal ethics committee of KU Leuven. We used 32 adult male C57Bl/6 mice of 8 wk of age (Janvier, Le Genest, France), kept on food and water ad libitum. The mice were divided in four experimental (E1-E4) and four control (C1-C4) groups (n ϭ 4/group) and subjected to different longitudinal lung micro-CT imaging schedules (Fig. 1) . After the last imaging time point, all mice were killed, ex vivo micro-CT data were acquired (E1-E4, C1, and C3), and the lungs were isolated for histological and biochemical evaluation of potential radiation-induced lung damage.
micro-CT Imaging
For the acquisition of in vivo lung micro-CT scans, mice were anesthetized with 1.5-2% isoflurane in 100% oxygen. Retrospectively respiratory-gated four-dimensional (4D) micro-CT datasets were acquired on a dedicated small animal micro-CT scanner (SkyScan 1076; Bruker microCT, Kontich, Belgium) as described (9) . Scan parameters were as follows: 50-kVp X-ray source voltage combined with a 0.5-mm aluminum filter, 180-A source current, 120-ms exposure time/projection, acquiring 9 projections/position with 0.7°increments over a total angle of 180°and field of view (FOV) covering the lung, resulting in a scanning time of 12 min and yielding four reconstructed three-dimensional datasets with (35 m) 3 isotropic voxel size corresponding to four different phases of the breathing cycle (4D). For the single high-dose scan, exposure time was tripled to 450 ms. Ex vivo micro-CT scans were acquired using the same settings, acquiring two projections per position.
Image Analysis
micro-CT data were retrospectively gated, reconstructed, visualized, and processed using software provided by the manufacturer (TSort, NRecon, DataViewer, CTan). Segmentation and quantification of the aerated lung volume were performed using a custom written automated algorithm that was applied to all datasets as defined, validated, and described previously (9) . Quantification of the mean lung signal intensity (SI, corresponding to CT number, expressed in gray values) and total lung volume was done for a volume of interest covering the lung, comprised of regions of interest that were manually delineated on the coronal micro-CT images at end-expiration, thereby avoiding the heart and main blood vessels (39) . The lung tissue volume was calculated as total lung volume minus aerated lung volume. The interobserver (n ϭ 3) agreement on data quantification was analyzed and found to be excellent (mean Pearson's correlation coefficient ϭ 0.827, P Ͻ 0.0001).
Dosimetry and Estimation of Absorbed Dose
Dosimetry and estimation of absorbed dose. The radiation dose of an in vivo lung micro-CT scan was experimentally assessed with TLDs (n ϭ 3) that were placed in the scanner while using the described micro-CT scanning protocol. The TLDs were calibrated with a 0.6-cm 3 thimble ionization chamber (type FC-65-G; IBA Dosimetry) that has a (air kerma, defined as the sum of the initial kinetic energies of all the charged particles liberated by uncharged ionizing radiation in a sample of matter, divided by the mass of the sample) calibration factor traceable to a standard dosimetry lab (PTB, Braunschweig, Germany) (27) , placed at the center of rotation of the scanner while using the same scanning protocol. Lung dose was measured by introducing TLDs (n ϭ 3) in the lung of a dead mouse and skin dose by placing TLDs (n ϭ 3) on the skin of a mouse (43) . All measurements were repeated three times and reported as means Ϯ SD.
The absorbed dose and its tissue distribution were simulated and estimated using the Monte Carlo methods. The simulation was designed and run by two independent researchers (Researchers 1 and 2), yielding reproducible and consistent simulation methods and results.
The simulations by Researcher 1 were performed using the Monte Carlo code MCNPX, version 2.5.0. A simplified micro-CT scanner geometry was used, consisting of 18 cone-shaped sources, equally distributed over 360°. The solid angle emission of each source was defined so that the mouse could be entirely irradiated by each source. The different sources were uniformly sampled during particle generation. According to data received by the scanner manufacturer, we described the energy of the X-rays of each source using an appropriate spectrum. Cut-off energies for all particles included in the problem (photons and electrons) were kept to the minimum (1 keV). An energy tally (score) was used at each region (bone soft tissue and lungs). We also calculated the deposited energy in a lattice, superimposed to the original geometry, with 5% uncertainties on the measured dose at the level of the lung. The input geometry was generated using a plugin of the free software ImageJ (NIH, Bethesda, MD). This starts from segmented micro-CT images (representing bone, soft tissue, and lungs) and converts them into a suitable input file for MCNPX, where each voxel is assigned to a particular material class.
The simulations by Researcher 2 were performed using the Geant4-based simulation package GAMOS (1). The simulation workflow consisted of the following two parts: simulation of the X-ray beam as it leaves the X-ray tube and the energy deposition of those X-rays in the tissue. The production of the X-ray beam is simulated by firing a fixed number of electrons on a tungsten target. The energy of the electrons is determined by the X-ray tube voltage (e.g., 50 kVp). The real-world time is related to the fixed number of electrons simulated via the X-ray tube current setting. The electron interactions that generate X-rays and the possible interactions of these X-rays in the target material or the beryllium exit window of the X-ray tube are fully simulated. To determine the dose deposited by the X-ray beam in the mouse, a CT scan of the mouse was segmented in the following three components: soft tissue, lung tissue, and bone. From this segmented image, a digital voxelized phantom was generated and imported in the simulation package. The compositions of soft tissue, lung tissue, and bone are specified in the simulation according to the NIST material data for tissue, lung, and cortical bone. When the X-rays from the previously generated X-ray beam pass through the digitized phantom, possible interactions are simulated, and the energy loss is attributed to the voxel where the interaction occurred. In a real CT scan, the X-ray tube is rotated around the animal in many small steps. To reduce the simulation time, only eight positions of the X-ray tube were simulated. The eight positions were uniformly distributed over 360°. The final amount of energy deposited in each voxel in the digitized mouse image is the sum of these eight simulations. To obtain the dose in a voxel, the total amount of energy in each voxel is divided by the density of the voxel material. In the case of lung voxels, it was assumed that it consists of 33% lung tissue and 66% air. Finally, the voxel dose is scaled according to the total scan time of a real scan.
Regarding the reported output based on the Monte Carlo simulations of dose distribution, Researcher 1 calculated and represented the dose absorbed in lungs (i.e., for the organ as a whole, accounting for absorption in both air and lung tissue), soft tissue, and bone in a whole mouse relative to the estimated dose in the Farmer model for the ionization chamber (method 1). Researcher 2 estimated the absorbed dose in bone, soft tissue, and lung tissue (i.e., excluding the air in the lungs) in absolute terms for a slice at the level of the lungs in the FOV, using a validated X-ray beam simulation corresponding to the experimental setup and exact anatomical information from a segmented micro-CT slice as input for the dose estimation (method 2). The dose absorbed in a voxel is calculated as the energy of the absorbed X-rays divided by the mass of the tissue for that voxel.
Histological Analysis and Hydroxyproline Quantification
The left lung was collected for histopathology, inflated with 400 l of 10% formalin/PBS via the left main bronchus, and fixed in formalin for 24 h. After being embedded in paraffin, 5-m sections were cut throughout the whole lung. Five sections, with 1-mm interval, were stained with hematoxylin-eosin and used to score pulmonary fibrosis (2) . Each successive field was given an Ashcroft score ranging from zero (normal) to eight (total fibrous obliteration of the field). All scores from five sections were averaged. The right lung lobes were used for collagen (hydroxyproline) quantification as described (44) . Histopathological sections were examined using an Axioplan light microscope (Carl Zeiss, Oberkochen, Germany).
Statistics
Data were analyzed using Prism 5.04 (Graphpad Software, San Diego, CA). t-Tests and one-way ANOVA followed by the appropriate post hoc test were used to evaluate the differences between two or more groups. Differences with P values Ͻ0.05 were considered significant. -
Fig. 1. Longitudinal lung microcomputed tomography (micro-CT) scanning protocols. Schematic outline of the study setup and four micro-CT scanning regimes used in this study. A total number of 32 mice were divided in the following experimental and control groups (n ϭ 4/group): group E1, 1ϫ micro-CT/wk during 5 wk; group E2, 2ϫ micro-CT/wk during 5 wk; group E3, 2ϫ micro-CT/wk during 5 wk, including 1ϫ high-dose micro-CT scan in week 3; group E4, 1ϫ micro-CT/wk during 12 wk; group C1, age-matched once-scanned controls, 1ϫ micro-CT at 5 wk; group C2, age-matched never scanned controls, killed after 5 wk; group C3, age-matched once-scanned controls, 1ϫ micro-CT at 12 wk; and group C4, age-matched never scanned controls, killed after 12 wk.
ionization chamber TLDs Fig. 2 . Dosimetry. Axial (left) and sagittal (right) reconstructed micro-CT images of a dead mouse carrying three thermoluminescent dosimeters at the level of the lungs (TLDs, top) and of the ionization chamber (bottom) used for measuring the radiation dose of a typical lung micro-CT scan as used in this study.
RESULTS
X-Ray Exposure and Tissue-Specific Absorbed Dose During Retrospectively Respiratory-Gated Lung Micro-CT
To have an accurate measurement of the radiation exposure that is associated with a high-resolution micro-CT acquisition, we measured the air kinetic energy released per unit mass (kerma) during a single lung micro-CT scan using an ionization chamber and thermoluminescent dosimeters (TLDs). The air kerma for a single retrospectively gated micro-CT scan as measured by the ionization chamber was found to be 1.64 Ϯ 0.04 Gy (Fig. 2, bottom) . Air kerma measured by TLDs (n ϭ 3) placed in the FOV of the scanner was found to be 1.640 Ϯ 0.026 Gy.
In addition, to know the radiation dose delivered to a mouse during such a scan, we performed dose measurements using TLDs that were placed at the level of the skin and in the lungs of a dead mouse (Fig. 2, top) . These resulted in a measured skin dose of 1,104 Ϯ 240 mGy and a lung dose of 813 Ϯ 103 mGy/micro-CT acquisition.
Because the TLD measurements can be regarded as a "point" measurement of dose, we were further interested in how this dose is distributed throughout the tissues and organs of a scanned mouse. Therefore, we estimated the dose absorbed by the different tissues involved (lung tissue, bone, and soft tissues surrounding the lungs) by Monte Carlo calculations. The skin dose that was calculated from these simulations was 1,099 mGy (Fig. 3Aa) dose measured with the TLDs (1,104 Ϯ 240 mGy). The total dose averaged over a lung slice within the FOV was 1,130 mGy. The average absorbed dose in soft tissue was 900 mGy, in lung tissue (excluding the air in the lungs) was estimated to be 990 mGy, while the dose absorbed in bone reached 4.5 Gy (method 2, Fig. 3A, b and c) . Because the absorbed dose in a voxel of a specific tissue is defined as the ratio of absorbed X-ray energy per unit of tissue mass, these results mean that a voxel of lung tissue will absorb less radiation but also weighs less than soft tissue or bone. Therefore, in terms of dose, the ratio turns out to be slightly higher for lung tissue compared with soft tissue although both values are still very comparable as expected based on their mass attenuation coefficients (20) . Assuming that the average dose (measured by using an ionization chamber or TLDs) for the whole mouse is 100%, then the relative dose absorbed in bone was calculated to be 122%, in soft tissue 34%, and in the lungs (including air) 12% (method 1, Fig. 3B ). The simulated relative deposited energy in soft tissue and lungs (including air) is in agreement with the absolute dose simulations above since the actual lung tissue only makes up ϳ33% of a lung voxel while the remaining part is filled with air. Taken together, these data indicate that only a part of the total radiation dose delivered to a mouse during a micro-CT scan is absorbed by the lungs and, more specifically, the lung tissue.
No Indication of Radiation-Induced Lung Damage Was Detected by Lung Micro-CT
To evaluate a potential effect of lung damage induced by repeated lung micro-CT scanning on the micro-CT readout, healthy adult mice were subjected to repeated lung micro-CT scanning according to four different regimes, designed to meet the needs of preclinical applications in lung research, as schematically represented in Fig. 1 : weekly and biweekly scans during a time span of 5 wk and weekly scans during 12 consecutive weeks. An additional group underwent two times per week lung scans during 5 wk, including a tripled dose midterm to mimic the not uncommon situation that a scan needs to be repeated at the same time point, thereby increasing the cumulative dose that the animal is exposed to at that time. Upon visual inspection of the in vivo micro-CT images for individual mice, no focal spots of increased density that may correspond to inflamed or fibrotic areas could be identified compared with controls (Fig. 4) . No overt signs of possible other lung injuries such as neoplasms could be appreciated from the individual in vivo micro-CT images. Moreover, from ex vivo micro-CT images that may reveal more details since they are devoid of blurring due to residual, noncompensated respiratory motion, no signs of lung injury could be discerned (Fig. 4) . The absence of any appreciable lung damage on the images was corroborated by the quantitative in vivo micro-CT data (Fig.  5) . No differences in micro-CT-derived biomarkers [aerated lung volume, lung tissue volume (including potential lesions), total lung volume, or mean lung SI] were found for any of the experimental groups (E1-E4) compared with the corresponding control group (C1 and C3; Fig. 5 ). Taken together, the data indicate that no apparent radiation-induced lung damage was detected by micro-CT for either of the four evaluated scanning protocols.
No Evidence of Micro-CT-Induced Fibrosis on Histopathological Evaluation or Hydroxyproline Quantification
After the last scan at 5 or 12 wk, we scored the extent of lung fibrosis on lung sections and quantified the collagen content of lung samples to search for possible fibrotic lung injuries that might have remained undetected by micro-CT. Because a potential effect of one micro-CT scan in the once-scanned control groups cannot be excluded, we compared them also with an extra control group comprised of age-matched mice that were never scanned. Ashcroft scores for lung fibrosis were zero for all animals, and no differences in total lung collagen, as assessed by hydroxyproline quantification, could be found between scanned mice and controls, indicating that none of the longitudinal micro-CT scanning regimes induced lung fibrosis (Fig. 6A) . In addition, lung sections (6/animal) of all animals were carefully inspected by a lung pathologist for pathological (such as inflammatory), cellular, or architectural abnormalities and were found to show no signs of any differences compared
in vivo ex vivo Fig. 4 . In vivo and ex vivo lung micro-CT. Axial, end-expiratory lung micro-CT images acquired at the last in vivo imaging time point at 5 wk (groups E1, E2, E3, and C1) or 12 wk (groups E4 and C3) after baseline and corresponding ex vivo images for the same mouse, acquired after the last in vivo micro-CT scan.
with healthy lungs (Fig. 6B) . Moreover, none of the animals showed any signs of systemic distress such as weight loss or behavioral changes during the course of the experiment, consistent with the absence of systemic side effects of the X-ray dose.
DISCUSSION
Longitudinal micro-CT has shown to be very useful in preclinical lung research for providing dynamic, quantitative information of lung disease progression and therapy effects in free-breathing animals (9, 26, 40), thereby having many advantages complementary to gold standard postmortem molecular, cellular, and histological assays. Notwithstanding that, achieving a high signal-to-noise ratio in respiratory gated micro-CT images with extremely small voxel sizes, such as (35 m) 3 as is the case here, requires a relatively large radiation dose to the mouse that is about 1,000 times higher than a typical human chest CT examination. Therefore, concerns regarding potential radiotoxicity issues to the mouse lung due to repeated micro-CT itself are justified and need to be answered before in vivo micro-CT can be exploited to its full potential by the lung research community. mean lung SI (a.u.) s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n e d c o n t r o l s c a n n 8.0x10 6 6.0x10 6 4.0x10 6 2.0x10 6 0 8.0x10 6 6.0x10 6 4.0x10 6 2.0x10 6 0 8.0x10 6 6.0x10 6 4.0x10 6 2.0x10 6 0 8.0x10 6 6.0x10 6 4.0x10 6 2.0x10 6 0 8.0x10 6 6.0x10 6 4.0x10 6 2.0x10 6 0 8.0x10 6 6.0x10 6 4.0x10 6 2.0x10 6 0 8.0x10 6 6.0x10 6 4.0x10 6 2.0x10 6 0 8.0x10 6 6.0x10 6 4.0x10 6 2. To know the radiation dose delivered during a micro-CT scan, one cannot solely rely on calculating the dose by multiplying the tube current by the amount of projections and the exposure time per projection, since the result would underestimate the real dose. This is caused by a certain "dead time" in between the acquisitions of projection images and at discrete projection positions in micro-CT scanners, being the time needed for the detector to read the information, transfer it to the computer, and to store it, which needs to be added to the dose of a single projection image acquisition (7) .
We measured that a mouse is exposed to Ͼ1 Gy of radiation during a single lung micro-CT scan, of which up to ϳ0.9 Gy reaches the lungs and is absorbed in lung tissue. This is a relatively large radiation dose compared with other micro-CT protocols that yield lower resolution data and/or do not provide 4D data corresponding to the four phases of the respiratory cycle such as with our micro-CT protocol (8 -10, 17, 43) . Notwithstanding that, the radiation dose and dose rate of a single lung micro-CT acquisition is not expected to result in tissue, cell, or DNA damage that could affect the experimental outcome (7, 17, 21, 32, 34) . However, the cumulative dose of several Greys after repeated lung scanning during longitudinal micro-CT examinations does require caution, since potential cell and tissue damage to the lung becomes a concern, although animals are well able to recover from fractionated amounts and low dose rates of radiation exposure (10, 11, 14, 21, 29, 36 ).
Radiation-induced lung injury may arise depending on the total dose of radiation given, the fractionation schedule, the volume of lung irradiated, the existence of prior lung disease, and the use of chemotherapeutic drugs in the management of the disease (3, 18, 31) . The bulk of our knowledge regarding radiation toxicity to the lung originates from the radiotherapy field where the lung is the major dose-limiting organ for cancer radiotherapy. However, therapeutic radiation dose and dose rates used in radiotherapy research are at least an order of magnitude higher than the doses delivered during a micro-CT study (17, 22, (32) (33) (34) , and the results can therefore not be extrapolated to preclinical lung imaging studies. Nonetheless, the potential radiotoxicity of longitudinal lung micro-CT itself remains a hurdle in the implementation of micro-CT for experimental pulmonary research in spite of its advantages, until its safety for the lungs under investigation is fully established.
Here we report that mice did not show any signs of radiation-induced lung fibrosis or other lesions that would potentially interfere with the micro-CT images and quantitative read-outs for the lungs when scanned weekly during 5 and up to 12 wk. Doubling the scanning frequency to two times a week during 5 wk remained without any trace of a radiotoxic effect, indicating that the time resolution of lung micro-CT scanning can be safely increased within the given time frame. A single tripling of the radiation dose also stayed within the limits of the mouse's repair capacity and remained without detectable symptoms or lung damage after 5 wk of scanning. This result ensures that, for instance, a failed scan can be safely and instantly repeated without jeopardizing the experimental outcome. We used C57Bl/6 mice, since they are widely used as an (transgenic) animal model in lung research and known to be a particular fibrosis-prone mouse strain (30, 33, 42) . By using gold standard histological methods for sensitive detection of potential radiation-induced lung fibrosis and careful examination of histological lung sections by a pathologist, we could exclude the occurrence of any possible early, intermediate, or late-stage histopathological changes following irradiation (31) that might not have reached the detection threshold of the micro-CT.
To the best of our knowledge, this is the first study assessing potential radiotoxic damage to the lungs during longitudinal respiratory-gated micro-CT scanning, providing evidence that longitudinal monitoring of mouse lungs using micro-CT is safe using the here evaluated (very) long-term and high-resolution 4D imaging protocols. A recent study also indicated that longitudinal micro-CT remains without radiotoxic side effects to heart and lungs after 6 wk of repeated scanning, albeit using a much lower resolution (and hence dose) micro-CT protocol (10) . This opens new perspectives for the long-term monitoring of lung conditions such as fibrosis, emphysema, chronic obstructive pulmonary disease, cancer, infections, and therapeutic response on an individual basis with high spatial and temporal resolution, without any concerns for radiation toxicity that may potentially interfere with the micro-CT readouts within the time frame of a typical experimental lung study. Our results also provide a safe conduct for the use of micro-CT to regularly follow up on pathology onset and progression in individual transgenic animals, overcoming issues regarding large interindividual variability (12) and obviating the need to kill valuable animals. Nonetheless, our study was limited to male, healthy animals, and we did not assess the possibly altered immune response of pathology after repeated X-ray imaging, nor did we investigate other potentially altered relevant readouts such as immune cell proliferation and apoptosis. One must bear in mind that repeated micro-CT may still have a confounding effect when studying lung disease models such as lung cancer, infection, or inflammation models that involve (rapidly dividing) cells, an immune reaction, tissue remodeling, or other responses from the host that can be differently sensitive to the radiation exposure of longitudinal micro-CT. In these cases, we recommend controlling for a possible effect of radiation on the disease induced for the specific model and imaging protocol, although we expect a potential effect to be minor and small compared with the interindividual variation regarding disease itself. Where it may prove necessary but difficult to unravel subtle confounding radiation effects from intrinsic variation of the disease model, recent developments made in lung magnetic resonance imaging may provide an alternative that is devoid of any concerns regarding the use of radiation (5, 39, 40) .
Looking toward the future, improving image resolution without having to compromise on radiation toxicity (i.e., by improving hardware and/or software) may bring even better image quality and the visualization of ground-glass opacities and honeycombing, etc., within reach of small animal CT, which would be beneficial for the translation of imaging examination results from mouse to man and back. Although image quality and radiation dose are always a tradeoff (27, 43) , micro-CT is likely to become even safer as efforts are undertaken to optimize scan and reconstruction parameters that will enable us to maximize resolution further while minimizing dose (8, 35, 37) .
In conclusion, longitudinal respiratory-gated lung micro-CT studies provide high-quality images and quantitative biomarkers for dynamic follow up of fibrosis, emphysema, transgenic animals, and other lung disease models while being safe for the animal under investigation, yielding accurate quantitative information without side effects of the in vivo X-ray exposure. This paves the way for the routine use of micro-CT in preclinical lung research.
